ストックスクリーナーアプリを入手
77.56
1.23%
0.87
前日終値:
$76.69
開ける：
$76.65
24時間の取引高:
1.90M
Relative Volume:
0.26
時価総額：
$98.37B
収益：
$386.46B
当期純損益:
$4.49B
株価収益率:
21.64
EPS:
3.5841
ネットキャッシュフロー:
$4.78B
1週間 パフォーマンス:
-5.24%
1か月 パフォーマンス:
+2.98%
6か月 パフォーマンス:
+16.38%
1年 パフォーマンス:
+37.50%
1日の値動き範囲:
$76.12
$78.03
1週間の範囲:
$75.92
$85.15
52週間の値動き範囲:
$43.56
$85.15
Cvs Health Corp Stock (CVS) Company Profile
CVS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
77.56 | 97.35B | 386.46B | 4.49B | 4.78B | 3.5841 |
|
UNH
Unitedhealth Group Inc
|
345.09 | 312.29B | 435.16B | 18.37B | 17.37B | 19.16 |
|
ELV
Elevance Health Inc
|
317.72 | 71.55B | 194.82B | 5.53B | 3.77B | 24.45 |
|
CI
Cigna Group
|
246.15 | 65.99B | 261.22B | 5.40B | 3.94B | 18.31 |
|
HUM
Humana Inc
|
283.06 | 34.35B | 123.11B | 1.58B | 2.44B | 13.03 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-14 | 開始されました | Goldman | Buy |
| 2025-08-18 | アップグレード | UBS | Neutral → Buy |
| 2025-08-14 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | アップグレード | Edward Jones | Hold → Buy |
| 2024-12-03 | アップグレード | Deutsche Bank | Hold → Buy |
| 2024-11-18 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | アップグレード | Barclays | Equal Weight → Overweight |
| 2024-10-04 | アップグレード | TD Cowen | Hold → Buy |
| 2024-05-30 | 開始されました | Robert W. Baird | Neutral |
| 2024-05-07 | ダウングレード | TD Cowen | Buy → Hold |
| 2024-05-02 | ダウングレード | UBS | Buy → Neutral |
| 2024-05-01 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | 開始されました | Barclays | Equal Weight |
| 2024-02-26 | 開始されました | Leerink Partners | Outperform |
| 2023-12-22 | 開始されました | HSBC Securities | Buy |
| 2023-09-19 | アップグレード | Evercore ISI | In-line → Outperform |
| 2023-09-12 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | ダウングレード | Edward Jones | Buy → Hold |
| 2023-05-26 | 開始されました | Piper Sandler | Overweight |
| 2023-04-21 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-01-03 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-11-23 | 再開されました | Morgan Stanley | Overweight |
| 2022-06-17 | 開始されました | Loop Capital | Buy |
| 2022-05-27 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-02-11 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | 開始されました | Goldman | Buy |
| 2021-12-01 | 開始されました | Seaport Research Partners | Buy |
| 2021-05-19 | 開始されました | Wells Fargo | Equal Weight |
| 2021-03-17 | ダウングレード | Guggenheim | Buy → Neutral |
| 2021-01-08 | アップグレード | Jefferies | Hold → Buy |
| 2020-09-17 | 開始されました | Piper Sandler | Overweight |
| 2020-07-01 | 開始されました | SVB Leerink | Mkt Perform |
| 2020-05-14 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | 再開されました | RBC Capital Mkts | Outperform |
| 2019-09-12 | 開始されました | Deutsche Bank | Buy |
| 2019-06-05 | アップグレード | Standpoint Research | Hold → Buy |
| 2019-04-29 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | 開始されました | Guggenheim | Buy |
| 2019-04-15 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2019-04-10 | 繰り返されました | BofA/Merrill | Buy |
| 2019-03-13 | 開始されました | Bernstein | Outperform |
| 2019-02-20 | ダウングレード | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | 開始されました | UBS | Buy |
| 2018-12-18 | 開始されました | Barclays | Overweight |
| 2018-11-29 | 再開されました | Goldman | Neutral |
| 2018-11-28 | 開始されました | Evercore ISI | Outperform |
| 2018-10-26 | 再開されました | Wolfe Research | Peer Perform |
| 2018-07-09 | アップグレード | Citigroup | Neutral → Buy |
| 2018-02-27 | 再開されました | BofA/Merrill | Buy |
| 2018-02-13 | 繰り返されました | Citigroup | Neutral |
すべてを表示
Cvs Health Corp (CVS) 最新ニュース
Impact Partnership Wealth LLC Takes Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Carret Asset Management LLC - MarketBeat
CVS Health Corporation $CVS Stock Position Trimmed by Daymark Wealth Partners LLC - MarketBeat
Is CVS Health Corporation (Common Stock) (CVS0) stock a safe buy pre earnings2025 Market Overview & Daily Oversold Bounce Ideas - newser.com
Is CVS Health Corporation stock in correction or buying zoneMarket Performance Summary & Accurate Intraday Trading Signals - newser.com
Is CVS Health Corporation stock positioned for digital transformationEarnings Miss & AI Driven Stock Price Forecasts - newser.com
Will CVS Health Corporation (CVS) stock maintain strong growth2025 Price Momentum & Risk Controlled Stock Alerts - newser.com
Is CVS Health Corporation stock a top momentum playJuly 2025 Short Interest & Short-Term High Return Strategies - newser.com
Philly Accuses PBMs Of Knowingly Enabling Opioid Crisis - Law360
CVS Health to shut down 16 ‘underperforming' Oak Street Health clinics, including 1 in Chicago - MSN
CVS Stock Slips as $5.7 Billion Charge Overshadows Record Results - Yahoo! Finance Canada
CVS Stock: Evercore ISI Raises Price Target to $95, Maintains Ou - GuruFocus
Cardinal Health Inc. stock outperforms competitors on strong trading day - MarketWatch
CVS Health Grows Earnings And Outlook While Stock Stumbles - Finimize
Why CVS Health (CVS) Stock Is Falling Today - Barchart.com
CVS Health Corp (CVS) Q3 2025 Earnings Call Highlights: Strong R - GuruFocus
CVS Health to shut down 16 Oak Street Health clinics, including 1 in Chicago - NBC 5 Chicago
CVS Health Corp. Hits New 52-Week High of $85.15 - Markets Mojo
CVS Health (CVS) Rating Maintained by RBC Capital with Raised Pr - GuruFocus
CVS Health (CVS): Cantor Fitzgerald Raises Price Target to $95 | - GuruFocus
CVS Health (CVS) Analyst Rating Update: Target Price Raised by T - GuruFocus
CVS Health Stock Feels the Heat as $5.7B Write-Down Weighs on ‘Record’ Q3 - TipRanks
CVS Health Corporation (NYSE:CVS) Q3 2025 Earnings Call Transcript - Insider Monkey
Jennison Associates LLC Purchases 2,117,798 Shares of CVS Health Corporation $CVS - MarketBeat
CT health system, major insurer at odds over new contract. What it could mean for patients. - Hartford Courant
Is it time to cut losses on CVS Health CorporationEarnings Risk Report & Long-Term Investment Growth Plans - newser.com
CVS Health tops Q3 forecasts but absorbs hefty charge for struggling clinic business - WPRI.com
CVS Q3 Deep Dive: Pharmacy Gains, Aetna Turnaround, and PBM Transition Shape Outlook - Yahoo! Finance Canada
CVS Health Reports Record Revenue Despite Impairment - TipRanks
Decoding CVS Health Corp (CVS): A Strategic SWOT Insight - GuruFocus
Pharmacies Say $1.5B Damages Too Much In Fla. Opioid Suit - Law360
Short interest data insights for CVS Health CorporationJuly 2025 Fed Impact & Daily Growth Stock Tips - newser.com
UBS Turns More Bullish on CVS Health (CVS) with $96 Price Target - Insider Monkey
CVS Health Earnings Call Highlights Robust Growth and Strategic Adjustments - TipRanks
CVS Health tops third-quarter forecasts but absorbs hefty charge for struggling clinic business - The Boston Globe
CVS Health posts record Q3 revenue despite $5.7B write-down - The Business Journals
CVS Health forecasts double-digit earnings growth for 2026 - Yahoo! Finance Canada
CVS Health (NYSE:CVS) Hits New 12-Month HighTime to Buy? - MarketBeat
CVS Posts Strong Q3 Earnings, but Shares Show Little Movement - AOL.com
CVS Health Earnings: Turnaround Efforts Proceeding and Could Continue Boosting Profits in 2026 - Morningstar
CVS Health (CVS) Raises Full-Year 2025 Earnings Guidance - GuruFocus
CVS Health reports Q3 earnings beat, raises full-year guidance - Proactive financial news
CVS Health rethinks Oak Street Health strategy, raises guidance - Modern Healthcare
CVS Q3 tops Street but takes $5.3B charge on struggling health care delivery unit - Chain Store Age
CVS Health Delivers Confident Outlook After Q3 Performance, Stock Hits 52-Week High - Benzinga
CVS Stock Falls Despite Q3 Earnings & Revenue Beat, '25 EPS View Up - The Globe and Mail
CVS Prioritizes Membership Growth Over Expanding Clinic Numbers - GuruFocus
CVS Boosts 2025 Profit Outlook Third Time on Insurance Gains - Bloomberg.com
CVS Health Corp reports results for the quarter ended September 30Earnings Summary - TradingView
CVS Health (CVS) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo! Finance Canada
CVS to Scale Back Oak Street Clinic Expansions - GuruFocus
Cvs Health Corp (CVS) 財務データ
収益
当期純利益
現金流量
EPS
1.37%
0.57%
大文字化:
|
ボリューム (24 時間):